Shorter trial authorisation timelines for ATMP trials in the US are an advantage for biotechs, say experts. Although the ...

The future of American drug innovation is threatened by U.S. regulations that permit knockoff versions of new drugs to be ...

Novartis receives third FDA approval for oral Fabhalta® (iptacopan) – the first and only treatment approved in C3 glomerulopathy (C3G) Fabhalta is the only oral alternative complement pathway ...

After HHS Secretary Robert F. Kennedy Jr. hosted a roundtable on reducing regulations on stem cells earlier this month, ...

For the first time, scientists say, they have evidence that using a biologic drug to remove sticky beta amyloid plaques from ...

An international team of clinical collaborators, led by physician scientists from Dana-Farber Cancer Institute, performed a first-ever clinical test of the targeted therapy avapritinib in pediatric ...

The effort, dubbed “Operation Stork Speed,” aims to ensure “quality, safety, nutritional adequacy, and resilience” of infant ...

Health and Human Services Secretary Robert F. Kennedy, Jr., has turned his attention to infant formula, with the goal of ...

The future of American drug innovation is threatened by US regulations that permit knockoff versions of new drugs to be sold ...

TAMPA, Fla. - The FDA issued a retail recall of several popular acne treatment products due to elevated levels of benzene.

The United States has led the world in pharmaceutical innovation for decades by developing drugs that combat cancer, heart ...